Arkolith/Insider Trading/CMPI/Form 4

venBio Global Strategic GP II, L.P.

10% OwnerCheckmate Pharmaceuticals, Inc. (CMPI) · full profile →Form 4 · filed Apr 26, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 26, 2022Sell(S)65K$10.38$671K3.0M
Apr 25, 2022Sell(S)28K$10.39$287K3.1M
Apr 22, 2022Sell(S)37K$10.39$389K3.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-008985) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML